Myofibroblastic cell activation and neovascularization predict native liver survival and development of esophageal varices in biliary atresia

Table 2 Patient characteristics at the time of portoenterostomy

BA type	n(%)	Age at PE (d)	Bilirubin (μmol/L)	Conjugated bilirubin
II	3 (9.1)	102 (78-141)	186 (98-247)	162 (86-207)
III	26 (78.8)	64 (7-140)	172 (103-470)	117 (45-224)
IIIa	4 (12.1)	51 (37-81)	171 (103-201)	85 (69-109)
		P = 0.092	P = 0.838	P = 0.183

Data presented as median and range. Comparisons between groups were performed with Kruskal-Wallis test. BA: Biliary atresia; PE: Portoenterostomy.